_id
6911b9c8ccc777a4e85d6132
Ticker
GBIO
Name
Generation Bio Co
Exchange
NASDAQ
Address
301 Binney Street, Cambridge, MA, United States, 02142
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://generationbio.com
Description
Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Last Close
5.39
Volume
5620
Current Price
5.43
Change
0.7421150278293143
Last Updated
2025-11-30T19:13:05.267Z
Image
data:image/webp;base64,UklGRkoIAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSPMFAAANmS8wRPQ/TGRX2jZFspwFMTMz3f/1MDMzS0bP1Kxm0fysX5TmQvs1F5ALv/crYsoUdPndAi9Fv/crYsrciG6BWeunIC/glBi6BV6JzBSkeSJOX8CMX6KICZiAq+KWz2vhah/zYR8l11C+nmhS+wgjogfD9fR+HiZ9wAeJfyd9hOuLqZgyjO36QltKuqFHIvmQ64lkM2UFvFxPYFCwsDGur6LgqFBcbxmwBNj158YzQYVEoNCPg7KaEBmrHkX3CiNiy2T2Lg/wQN392ftlyPtw4w4SBR6kEcpGIKN8rl2poE0ByEjAqWSlACmAaczGOakBSKqdz8RmykUYJOG99nyQ21/Y2/UjITWuqMV3yO/2EE/AZgwvgiEJTLm5CPXYUypOXcdG49tkjW6mzFPOfuKBAU7MrhPKvRqDS4awAJw6GkmIOjbSBOZGQP49cgHc/FHCSy0fzmE295rmTyb18mWeCHN7qFGIGKbsNv4l6g1LP6YuUZ72q5PHyy805Qk6L36Mj8U4VOL6ByXpBTChLkyYZSAvJb/aYqUaBWWz3D4Gc4rj6HiXv58vMCsR2pRkb8alyQDQGIxnIHfw42zrP805RUTr2j3eqF49V/pZ2KwpLu8EAMnLpAzjso8BPCMMBcAQHeUz/INEWpBF8spcG5aPpiKrP75JXjEAeqsMt2oooWywGDHLgOHACd7aZypvAEITKf4tPU23iWfpedJgQRwAGsWGrijMN1GbtjYcsV5skrwOZp0tSWJp2n+tOjjpVwBskfXi6ZZGOnpO7b36GvEI+ax7BhzOkMWrhKco3R2DERMDyNF2OwKAYVmnMTT77RHESnt2GKDyFiK88ZaWaAAg0PBtwixDrsRvdfPVogIb8h4WqkDr/H/eXWzzyB2AHF0RHKre9/3XFNWtQY3qc9+HnU5NDQfAyq4sD0PXi+QjUOiwPYKGlHOG8wwAah1bBQzeYiUDChsfAQUUGDljNsGgVZTNuAqQYDgSF4AhogxDsmRR02ElxYCqpsxqWbVaSRYTbOSEDFWl3nC4FltWYqgaRUZ1deKBMLKzDCtJgjc+qEFvqZJpbhEpVysFJAhYq9MJ2c1xLiMO1N10RlJXAWDt5KNxla4svSEmrwlioMKDLbdtAut8m+OKUZUBYddM56johjhNrZwnYzOXEeL+OfBKvUQ3NPWV6fX+hKNG0jv709M7+SB34ezKncjhWioTr0axcWgcEDNHjqG/jCNTTO3u/2FLygAPQ+77Vm2bdF/78iSbS4ijNS9QFj33Ndd/wnV4frGjv9f1ojU0XWL/1aHFHWjd3PpU5jqBxsE5MsJ8yDAGW7Wc+HLT7q5kNS0SrfcD+rpp3QnRZPoJW4P6JTcFjQBh9H/C8hA1GLzvP9c2J7fGMbLPceI91udp+MG3ugCsS7PpeoIJAYDU45BWlg/JrDrGHKaxYPBJDZgrpPbNvoUhxfFvr9UO97VxEmIzitukX/v3kiIANrPIMFcsXGr/naZASgmI/Vnabz4LAuCCz0tNqg2xiDGnpBp6AQBhpWi+qOwk9KsmWIkslmnw2u7/JZhtaHy9z3hddUXFqHTNv+XeOu0BmEC5jkN3rftW92zXX00bVxSwxKl1OuLQoufbIElUkchSOh1cEAAg5sKnKmD8KydEDVQYbNAmLgyHcos5TieSoKU4wtjwme4ASKaU8LVeU14DjRHl7FVT0eRRtYOZJfNZrZABQ/t/r1gDURv2wBwHM4BgwkaoPjejO6LDaWaYlCbRQq/cygCC7phwxAbXoRKZ5S7BohGMUsjZM4B8xc2XOIaZzvG1ssIn0jqIR4xxjHMA6Bttt8fBiy933lGfFMCEKWNzwQDsfLvnNY7jWhbt/uTS6aiNU2MgCADZavcsosdCzITTxnzOqOi3u6bg/ziWJ+G8v9Rd3hFyFANAEvOiDL+yPY4nE+WJmBsgwVhgksypLk9xXBPierwnXAz7wkws7FxTNq+H4+yo9oCKsoIFWvi8xvG+FoT8aCEhaVE3BRx/BSywMUME11eGieBGFwBWUDggMAIAABAMAJ0BKkAAQAA+tUqeSickIqGx9xkg4BaJbGxtR9kgGeAPtA/ACqRCVK4TfEJBlt4ND/ySpfgaQJlPSAGpZIh8blnuwpe6OaFQwCIYB5/E0oQWARceNYmXjiFYjb518aK/N4///ec6AAD+/BL/8/H+ehhQBj6JZ/lPiZJiSSl9rRziFJLofyPDvJBGJWCNy9L45CnxOCraySkHgwQtUCYKrujfaCjDOKif9+//7gB/uF/KjTkPLnhPHzcqh8AwFPY3yPr+rO3iEf5g86E8Bg5fOv2vWjKwFxKDPq4XPGbRyqrJQijcp7xiRjpONbB+MnVDKlBfv5hUFp1IITCHdpS/QNcJv3MOhkbXvh99a69J3l595m59m6oytu3EO8wXRO6Y5Ra3zHKrBJhUC5xcBop7n9FNbtNX27/QlzwdhOgdn4bmlWl2ykNjBSsROWTFbJA0NEQ6gBmF/zYF8hkWHutNW/uKERMO1mr3IalTCRvszgY2zWnaP7rAnyldH/SPCM1MNk04PWknk8L4wY3GKfwQTTeEHf+ZPy+LyflsF5YfbA0UuOF1OPZIPG2VNjDWi72YBfgdjE9zOQFpVogPsJptjWSir08yXPWm+ncmNauUIbuKG+FcYrt6s6aJ4ZgADT5CVldN9/iTg+6elnqH5CrfcLrSFGuZVpyAR4QqAOz412GQ4trmNuyoqvHxd/fQoUvBza8eB2+4/fw/7zP/22D/bP+SUQM+bHNMoCTIAAAA
Ipo Date
2020-06-12T00:00:00.000Z
Market Cap
35913000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
9.3333
Strong Buy
3
Buy
1
Hold
3
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1594000
Cost Of Revenue
1404000
Gross Profit
190000
Operating Expenses
21688000
Operating Income
-21498000
Interest Expense
-
Pretax Income
-5520000
Net Income
-5520000
Eps
-0.8195438644521958
Dividends Per Share
-
Shares Outstanding
6737899
Income Tax Expense
-
EBITDA
-4116000
Operating Margin
-1348.6825595984942
Total Other Income Expense Net
15978000
Cash
21940000
Short Term Investments
67682000
Receivables
-
Inventories
-
Total Current Assets
93462000
Property Plant Equipment
26282000
Total Assets
121896000
Payables
2064000
Short Term Debt
6352000
Long Term Debt
-
Total Liabilities
71336000
Equity
50560000
Depreciation
1404000
Change In Working Capital
-26405000
Cash From Operations
-52680000
Capital Expenditures
0
Cash From Investing
25528000
Cash From Financing
-2000
Net Change In Cash
-27154000
PE
-
PB
0.7233685763449367
ROE
-10.917721518987342
ROA
-4.528450482378421
FCF
-52680000
Fcf Percent
-33.04893350062735
Piotroski FScore
0
Health Score
23
Deep Value Investing Score
4.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
3.5
Net Net Investing Score
3.5
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1594000
Quarters > 0 > income Statement > cost Of Revenue
1404000
Quarters > 0 > income Statement > gross Profit
190000
Quarters > 0 > income Statement > operating Expenses
21688000
Quarters > 0 > income Statement > operating Income
-21498000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-5520000
Quarters > 0 > income Statement > net Income
-5520000
Quarters > 0 > income Statement > eps
-0.8195438644521958
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
6735454
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4116000
Quarters > 0 > income Statement > operating Margin
-1348.6825595984942
Quarters > 0 > income Statement > total Other Income Expense Net
15978000
Quarters > 0 > balance Sheet > cash
21940000
Quarters > 0 > balance Sheet > short Term Investments
67682000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
93462000
Quarters > 0 > balance Sheet > property Plant Equipment
26282000
Quarters > 0 > balance Sheet > total Assets
121896000
Quarters > 0 > balance Sheet > payables
2064000
Quarters > 0 > balance Sheet > short Term Debt
6352000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
71336000
Quarters > 0 > balance Sheet > equity
50560000
Quarters > 0 > cash Flow > net Income
-5520000
Quarters > 0 > cash Flow > depreciation
1404000
Quarters > 0 > cash Flow > change In Working Capital
-26405000
Quarters > 0 > cash Flow > cash From Operations
-52680000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
25528000
Quarters > 0 > cash Flow > cash From Financing
-2000
Quarters > 0 > cash Flow > net Change In Cash
-27154000
Quarters > 0 > ratios > PE
-0.8195438644521958
Quarters > 0 > ratios > PB
0.7233685763449367
Quarters > 0 > ratios > ROE
-10.917721518987342
Quarters > 0 > ratios > ROA
-4.528450482378421
Quarters > 0 > ratios > FCF
-52680000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-33.04893350062735
Quarters > 0 > health Score
23
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
765000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
765000
Quarters > 1 > income Statement > operating Expenses
23681000
Quarters > 1 > income Statement > operating Income
-22916000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-20923000
Quarters > 1 > income Statement > net Income
-20923000
Quarters > 1 > income Statement > eps
-3.1211652986923717
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
6703586
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-21268000
Quarters > 1 > income Statement > operating Margin
-2995.5555555555557
Quarters > 1 > income Statement > total Other Income Expense Net
1993000
Quarters > 1 > balance Sheet > cash
49094000
Quarters > 1 > balance Sheet > short Term Investments
92269000
Quarters > 1 > balance Sheet > receivables
256000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
145502000
Quarters > 1 > balance Sheet > property Plant Equipment
31711000
Quarters > 1 > balance Sheet > total Assets
179432000
Quarters > 1 > balance Sheet > payables
2232000
Quarters > 1 > balance Sheet > short Term Debt
9752000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
125331000
Quarters > 1 > balance Sheet > equity
54101000
Quarters > 1 > cash Flow > net Income
-20923000
Quarters > 1 > cash Flow > depreciation
1134000
Quarters > 1 > cash Flow > change In Working Capital
1783000
Quarters > 1 > cash Flow > cash From Operations
-16828000
Quarters > 1 > cash Flow > capital Expenditures
459000
Quarters > 1 > cash Flow > cash From Investing
14951000
Quarters > 1 > cash Flow > cash From Financing
80000
Quarters > 1 > cash Flow > net Change In Cash
-1797000
Quarters > 1 > ratios > PE
-3.1211652986923717
Quarters > 1 > ratios > PB
0.6728243836527975
Quarters > 1 > ratios > ROE
-38.67396166429456
Quarters > 1 > ratios > ROA
-11.660684827678452
Quarters > 1 > ratios > FCF
-17287000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-22.597385620915034
Quarters > 1 > health Score
20
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
8723000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
8723000
Quarters > 2 > income Statement > operating Expenses
25329000
Quarters > 2 > income Statement > operating Income
-16606000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-14802000
Quarters > 2 > income Statement > net Income
-14802000
Quarters > 2 > income Statement > eps
-2.209170969863666
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
6700251
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-14332000
Quarters > 2 > income Statement > operating Margin
-190.3702854522527
Quarters > 2 > income Statement > total Other Income Expense Net
1804000
Quarters > 2 > balance Sheet > cash
50891000
Quarters > 2 > balance Sheet > short Term Investments
106668000
Quarters > 2 > balance Sheet > receivables
1392000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
165119000
Quarters > 2 > balance Sheet > property Plant Equipment
33807000
Quarters > 2 > balance Sheet > total Assets
201348000
Quarters > 2 > balance Sheet > payables
2262000
Quarters > 2 > balance Sheet > short Term Debt
9463000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
128016000
Quarters > 2 > balance Sheet > equity
73332000
Quarters > 2 > cash Flow > net Income
-14802000
Quarters > 2 > cash Flow > depreciation
1136000
Quarters > 2 > cash Flow > change In Working Capital
-16852000
Quarters > 2 > cash Flow > cash From Operations
-28360000
Quarters > 2 > cash Flow > capital Expenditures
246000
Quarters > 2 > cash Flow > cash From Investing
2957000
Quarters > 2 > cash Flow > cash From Financing
-7000
Quarters > 2 > cash Flow > net Change In Cash
-25410000
Quarters > 2 > ratios > PE
-2.209170969863666
Quarters > 2 > ratios > PB
0.4961321514482081
Quarters > 2 > ratios > ROE
-20.18491245295369
Quarters > 2 > ratios > ROA
-7.351451218785386
Quarters > 2 > ratios > FCF
-28606000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-3.2793763613435742
Quarters > 2 > health Score
23
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
4188000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
4188000
Quarters > 3 > income Statement > operating Expenses
27751000
Quarters > 3 > income Statement > operating Income
-23563000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-21382000
Quarters > 3 > income Statement > net Income
-21382000
Quarters > 3 > income Statement > eps
-3.2038497741781877
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
6673846
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-18786000
Quarters > 3 > income Statement > operating Margin
-562.6313276026743
Quarters > 3 > income Statement > total Other Income Expense Net
2181000
Quarters > 3 > balance Sheet > cash
76301000
Quarters > 3 > balance Sheet > short Term Investments
108922000
Quarters > 3 > balance Sheet > receivables
1559000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
192903000
Quarters > 3 > balance Sheet > property Plant Equipment
35603000
Quarters > 3 > balance Sheet > total Assets
231197000
Quarters > 3 > balance Sheet > payables
1408000
Quarters > 3 > balance Sheet > short Term Debt
13006000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
144993000
Quarters > 3 > balance Sheet > equity
86204000
Quarters > 3 > cash Flow > net Income
-21382000
Quarters > 3 > cash Flow > depreciation
1176000
Quarters > 3 > cash Flow > change In Working Capital
-875000
Quarters > 3 > cash Flow > cash From Operations
-15784000
Quarters > 3 > cash Flow > capital Expenditures
377999
Quarters > 3 > cash Flow > cash From Investing
70284000
Quarters > 3 > cash Flow > cash From Financing
144000
Quarters > 3 > cash Flow > net Change In Cash
54644000
Quarters > 3 > ratios > PE
-3.2038497741781877
Quarters > 3 > ratios > PB
0.4203863368289174
Quarters > 3 > ratios > ROE
-24.80395341283467
Quarters > 3 > ratios > ROA
-9.248389901253045
Quarters > 3 > ratios > FCF
-16161999
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-3.85912106017192
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
19892000
Annuals > 0 > income Statement > cost Of Revenue
4931000
Annuals > 0 > income Statement > gross Profit
19892000
Annuals > 0 > income Statement > operating Expenses
162282000
Annuals > 0 > income Statement > operating Income
-142390000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-131668000
Annuals > 0 > income Statement > net Income
-131668000
Annuals > 0 > income Statement > eps
-19.762777031302722
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
6662424
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-74262000
Annuals > 0 > income Statement > operating Margin
-715.8154031771567
Annuals > 0 > income Statement > total Other Income Expense Net
10722000
Annuals > 0 > balance Sheet > cash
76301000
Annuals > 0 > balance Sheet > short Term Investments
108922000
Annuals > 0 > balance Sheet > receivables
1559000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
192903000
Annuals > 0 > balance Sheet > property Plant Equipment
35603000
Annuals > 0 > balance Sheet > total Assets
231197000
Annuals > 0 > balance Sheet > payables
1408000
Annuals > 0 > balance Sheet > short Term Debt
13006000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
144993000
Annuals > 0 > balance Sheet > equity
86204000
Annuals > 0 > cash Flow > net Income
-131668000
Annuals > 0 > cash Flow > depreciation
4931000
Annuals > 0 > cash Flow > change In Working Capital
-31429000
Annuals > 0 > cash Flow > cash From Operations
-88563000
Annuals > 0 > cash Flow > capital Expenditures
2401000
Annuals > 0 > cash Flow > cash From Investing
94529000
Annuals > 0 > cash Flow > cash From Financing
250000
Annuals > 0 > cash Flow > net Change In Cash
6216000
Annuals > 0 > ratios > PE
-19.762777031302722
Annuals > 0 > ratios > PB
0.4119381921952578
Annuals > 0 > ratios > ROE
-152.74001206440536
Annuals > 0 > ratios > ROA
-56.95056596755148
Annuals > 0 > ratios > FCF
-90964000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-4.572893625578122
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
5904000
Annuals > 1 > income Statement > cost Of Revenue
5263000
Annuals > 1 > income Statement > gross Profit
5904000
Annuals > 1 > income Statement > operating Expenses
144467000
Annuals > 1 > income Statement > operating Income
-138563000
Annuals > 1 > income Statement > interest Expense
11951000
Annuals > 1 > income Statement > pretax Income
-126612000
Annuals > 1 > income Statement > net Income
-126612000
Annuals > 1 > income Statement > eps
-1.9634784205328741
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
64483520
Annuals > 1 > income Statement > income Tax Expense
5095105
Annuals > 1 > income Statement > EBITDA
-133300000
Annuals > 1 > income Statement > operating Margin
-2346.9342818428186
Annuals > 1 > income Statement > total Other Income Expense Net
11951000
Annuals > 1 > balance Sheet > cash
66446000
Annuals > 1 > balance Sheet > short Term Investments
197918000
Annuals > 1 > balance Sheet > receivables
4148000
Annuals > 1 > balance Sheet > inventories
3816000
Annuals > 1 > balance Sheet > total Current Assets
272618000
Annuals > 1 > balance Sheet > property Plant Equipment
95651000
Annuals > 1 > balance Sheet > total Assets
374758000
Annuals > 1 > balance Sheet > payables
2346000
Annuals > 1 > balance Sheet > short Term Debt
8120000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
171630000
Annuals > 1 > balance Sheet > equity
203128000
Annuals > 1 > cash Flow > net Income
-126612000
Annuals > 1 > cash Flow > depreciation
5263000
Annuals > 1 > cash Flow > change In Working Capital
53537000
Annuals > 1 > cash Flow > cash From Operations
-52745000
Annuals > 1 > cash Flow > capital Expenditures
7397000
Annuals > 1 > cash Flow > cash From Investing
-9698000
Annuals > 1 > cash Flow > cash From Financing
35817000
Annuals > 1 > cash Flow > net Change In Cash
-26626000
Annuals > 1 > ratios > PE
-1.9634784205328741
Annuals > 1 > ratios > PB
1.6920225749281241
Annuals > 1 > ratios > ROE
-62.331140955456654
Annuals > 1 > ratios > ROA
-33.785002588337
Annuals > 1 > ratios > FCF
-60142000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-10.186653116531165
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
880000
Annuals > 2 > income Statement > cost Of Revenue
5130000
Annuals > 2 > income Statement > gross Profit
-5130000
Annuals > 2 > income Statement > operating Expenses
141182000
Annuals > 2 > income Statement > operating Income
-141182000
Annuals > 2 > income Statement > interest Expense
4543000
Annuals > 2 > income Statement > pretax Income
-136639000
Annuals > 2 > income Statement > net Income
-132096000
Annuals > 2 > income Statement > eps
-22.73014712752618
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
5811489
Annuals > 2 > income Statement > income Tax Expense
-4543000
Annuals > 2 > income Statement > EBITDA
-136052000
Annuals > 2 > income Statement > operating Margin
-16043.409090909092
Annuals > 2 > income Statement > total Other Income Expense Net
4543000
Annuals > 2 > balance Sheet > cash
93171000
Annuals > 2 > balance Sheet > short Term Investments
185920000
Annuals > 2 > balance Sheet > receivables
660000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
287016000
Annuals > 2 > balance Sheet > property Plant Equipment
81423000
Annuals > 2 > balance Sheet > total Assets
376264000
Annuals > 2 > balance Sheet > payables
662000
Annuals > 2 > balance Sheet > short Term Debt
7086000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
93771000
Annuals > 2 > balance Sheet > equity
282493000
Annuals > 2 > cash Flow > net Income
-136639000
Annuals > 2 > cash Flow > depreciation
5130000
Annuals > 2 > cash Flow > change In Working Capital
1046000
Annuals > 2 > cash Flow > cash From Operations
-102448000
Annuals > 2 > cash Flow > capital Expenditures
8801000
Annuals > 2 > cash Flow > cash From Investing
-192515000
Annuals > 2 > cash Flow > cash From Financing
12989000
Annuals > 2 > cash Flow > net Change In Cash
-281974000
Annuals > 2 > ratios > PE
-22.73014712752618
Annuals > 2 > ratios > PB
0.1096495713876096
Annuals > 2 > ratios > ROE
-46.76080469250565
Annuals > 2 > ratios > ROA
-35.107265111730065
Annuals > 2 > ratios > FCF
-111249000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-126.41931818181818
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
4532000
Annuals > 3 > income Statement > gross Profit
-4532000
Annuals > 3 > income Statement > operating Expenses
119101000
Annuals > 3 > income Statement > operating Income
-119101000
Annuals > 3 > income Statement > interest Expense
50000
Annuals > 3 > income Statement > pretax Income
-119151000
Annuals > 3 > income Statement > net Income
-114669000
Annuals > 3 > income Statement > eps
-20.36915982478142
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
5629540
Annuals > 3 > income Statement > income Tax Expense
-4482000
Annuals > 3 > income Statement > EBITDA
-114569000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-50000
Annuals > 3 > balance Sheet > cash
375145000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
403000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
379186000
Annuals > 3 > balance Sheet > property Plant Equipment
91029000
Annuals > 3 > balance Sheet > total Assets
476771000
Annuals > 3 > balance Sheet > payables
2023000
Annuals > 3 > balance Sheet > short Term Debt
4608000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
95025000
Annuals > 3 > balance Sheet > equity
381746000
Annuals > 3 > cash Flow > net Income
-119151000
Annuals > 3 > cash Flow > depreciation
4532000
Annuals > 3 > cash Flow > change In Working Capital
4175000
Annuals > 3 > cash Flow > cash From Operations
-91821000
Annuals > 3 > cash Flow > capital Expenditures
5958000
Annuals > 3 > cash Flow > cash From Investing
193047000
Annuals > 3 > cash Flow > cash From Financing
214671000
Annuals > 3 > cash Flow > net Change In Cash
315897000
Annuals > 3 > ratios > PE
-20.36915982478142
Annuals > 3 > ratios > PB
0.07860055691480722
Annuals > 3 > ratios > ROE
-30.038035761998817
Annuals > 3 > ratios > ROA
-24.05116921960438
Annuals > 3 > ratios > FCF
-97779000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.8195438644521958
Valuation > metrics > PB
0.7233685763449367
Valuation > final Score
70
Valuation > verdict
27.7% Undervalued
Profitability > metrics > ROE
-10.917721518987342
Profitability > metrics > ROA
-5.906143673364576
Profitability > metrics > Net Margin
-3.4629861982434127
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.4109177215189874
Risk > metrics > Interest Coverage
-15.311965811965813
Risk > final Score
-31
Risk > verdict
High
Liquidity > metrics > Current Ratio
11.10527566539924
Liquidity > metrics > Quick Ratio
11.10527566539924
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-248
Prev Risks > 1
-111
Prev Risks > 2
-6
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:31:47.826Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.82
Earnings History > 0 > eps Estimate
-0.28
Earnings History > 0 > eps Difference
-0.54
Earnings History > 0 > surprise Percent
-192.8571
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-3.12
Earnings History > 1 > eps Estimate
-0.2783
Earnings History > 1 > eps Difference
-2.8417
Earnings History > 1 > surprise Percent
-1021.0923
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.2039
Earnings History > 2 > eps Estimate
-0.41
Earnings History > 2 > eps Difference
0.2061
Earnings History > 2 > surprise Percent
50.2683
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-04
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2662
Earnings History > 3 > eps Estimate
-0.2536
Earnings History > 3 > eps Difference
-0.0126
Earnings History > 3 > surprise Percent
-4.9685
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.23
Earnings History > 4 > eps Estimate
-0.28
Earnings History > 4 > eps Difference
0.05
Earnings History > 4 > surprise Percent
17.8571
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-07
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.31
Earnings History > 5 > eps Estimate
-0.28
Earnings History > 5 > eps Difference
-0.03
Earnings History > 5 > surprise Percent
-10.7143
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-13
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.12
Earnings History > 6 > eps Estimate
-0.41
Earnings History > 6 > eps Difference
-0.71
Earnings History > 6 > surprise Percent
-173.1707
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-06
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.53
Earnings History > 7 > eps Estimate
-0.45
Earnings History > 7 > eps Difference
-0.08
Earnings History > 7 > surprise Percent
-17.7778
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.43
Earnings History > 8 > eps Estimate
-0.5
Earnings History > 8 > eps Difference
0.07
Earnings History > 8 > surprise Percent
14
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-02
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.47
Earnings History > 9 > eps Estimate
-0.5
Earnings History > 9 > eps Difference
0.03
Earnings History > 9 > surprise Percent
6
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.53
Earnings History > 10 > eps Estimate
-0.46
Earnings History > 10 > eps Difference
-0.07
Earnings History > 10 > surprise Percent
-15.2174
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.55
Earnings History > 11 > eps Estimate
-0.58
Earnings History > 11 > eps Difference
0.03
Earnings History > 11 > surprise Percent
5.1724
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.53
Earnings History > 12 > eps Estimate
-0.67
Earnings History > 12 > eps Difference
0.14
Earnings History > 12 > surprise Percent
20.8955
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.66
Earnings History > 13 > eps Estimate
-0.62
Earnings History > 13 > eps Difference
-0.04
Earnings History > 13 > surprise Percent
-6.4516
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-05
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.61
Earnings History > 14 > eps Estimate
-0.52
Earnings History > 14 > eps Difference
-0.09
Earnings History > 14 > surprise Percent
-17.3077
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.54
Earnings History > 15 > eps Estimate
-0.57
Earnings History > 15 > eps Difference
0.03
Earnings History > 15 > surprise Percent
5.2632
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.56
Earnings History > 16 > eps Estimate
-0.56
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-11
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.55
Earnings History > 17 > eps Estimate
-0.47
Earnings History > 17 > eps Difference
-0.08
Earnings History > 17 > surprise Percent
-17.0213
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-12
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.46
Earnings History > 18 > eps Estimate
-0.45
Earnings History > 18 > eps Difference
-0.01
Earnings History > 18 > surprise Percent
-2.2222
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-18
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.27
Earnings History > 19 > eps Estimate
-0.5
Earnings History > 19 > eps Difference
0.23
Earnings History > 19 > surprise Percent
46
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-10
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.46
Earnings History > 20 > eps Estimate
-0.45
Earnings History > 20 > eps Difference
-0.01
Earnings History > 20 > surprise Percent
-2.2222
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-11
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-1.5
Earnings History > 21 > eps Estimate
-0.6
Earnings History > 21 > eps Difference
-0.9
Earnings History > 21 > surprise Percent
-150
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-12
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.06
Earnings History > 22 > eps Estimate
-0.85
Earnings History > 22 > eps Difference
-0.21
Earnings History > 22 > surprise Percent
-24.7059
Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHere's Why We're A Bit Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation Yahoo Finance
Read more →Companies Like Generation Bio (NASDAQ:GBIO) Could Be Quite Risky simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$9.3333
Analyst Picks
Strong Buy
3
Buy
1
Hold
3
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 65.73% of the total shares of Generation Bio Co
1.
T. Rowe Price Associates, Inc.(12.5641%)
since
2025/06/30
2.
US Small-Cap Growth II Equity Comp(7.0597%)
since
2025/06/30
3.
T. Rowe Price New Horizons(7.0597%)
since
2025/07/31
4.
Siren, L.L.C.(4.4078%)
since
2025/06/30
5.
Renaissance Technologies Corp(3.8316%)
since
2025/06/30
6.
FMR Inc(3.4825%)
since
2025/06/30
7.
Vanguard Group Inc(3.4123%)
since
2025/06/30
8.
Vanguard Total Stock Mkt Idx Inv(2.2628%)
since
2025/07/31
9.
T. Rowe Price Health Sciences(2.0974%)
since
2025/07/31
10.
BlackRock Inc(1.7245%)
since
2025/06/30
11.
T. Rowe Price New Horizons Tr-A(1.5836%)
since
2025/06/30
12.
Goldman Sachs Group Inc(1.5798%)
since
2025/06/30
13.
Millennium Management LLC(1.5761%)
since
2025/06/30
14.
Yiheng Capital LLC(1.5667%)
since
2025/06/30
15.
Morgan Stanley - Brokerage Accounts(1.3552%)
since
2025/06/30
16.
UBS Group AG(1.3138%)
since
2025/06/30
17.
Bank of America Corp(1.2946%)
since
2025/06/30
18.
Militia Capital Partners, LP(0.8052%)
since
2025/06/30
19.
Squarepoint Ops LLC(0.7695%)
since
2025/06/30
20.
Geode Capital Management, LLC(0.7395%)
since
2025/06/30
21.
Vanguard Institutional Extnd Mkt Idx Tr(0.7324%)
since
2025/07/31
22.
TD Asset Management Inc(0.5058%)
since
2025/06/30
23.
Galileo - Biotech Innovation Fund S USD(0.4646%)
since
2025/02/28
24.
Fidelity Extended Market Index(0.3793%)
since
2025/07/31
25.
Susquehanna International Group, LLP(0.3701%)
since
2025/06/30
26.
Charles Schwab Investment Management Inc(0.3517%)
since
2025/06/30
27.
Fidelity Global Micro-Cap F(0.3266%)
since
2025/06/30
28.
State Street Corp(0.306%)
since
2025/06/30
29.
Citadel Advisors Llc(0.2853%)
since
2025/06/30
30.
T. Rowe Price U.S. Equities Tr(0.2637%)
since
2025/06/30
31.
TD Health Sciences - I(0.2529%)
since
2024/12/31
32.
Goldman Sachs Small Cp Val Insghts Instl(0.249%)
since
2025/04/30
33.
Extended Equity Market Fund K(0.1511%)
since
2025/06/30
34.
NT Ext Equity Mkt Idx Fd - NL(0.1087%)
since
2025/06/30
35.
T. Rowe Price US Small-Cap Growth Equity(0.1044%)
since
2025/06/30
36.
Northern Trust Extended Eq Market Idx(0.0862%)
since
2025/06/30
37.
NT Ext Equity Mkt Idx Fd - L(0.0862%)
since
2025/06/30
38.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0844%)
since
2025/06/30
39.
NT Col R2000 Val Idx Fd -DC -L -TierFour(0.0716%)
since
2025/03/31
40.
JHFunds2 Health Sciences NAV(0.0677%)
since
2025/01/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.82
EPS Estimate
-0.28
EPS Difference
-0.54
Surprise Percent
-192.8571%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.